Beta blockers could benefit patients with HFPEF
[PRESS RELEASE 11/16/2014] A novel registry study from Karolinska Institutet in Sweden suggests that beta blockers may benefit also patients suffering from a relatively unknown form of heart failure called HFPEF, which today lacks well-established treatment. HFPEF involves an impaired ability of the heart to fill with blood, and affects nearly 2 per cent of the population. These new findings are being published in the scientific periodical JAMA.Heart failure was for a long time defined as reduced ability to contract the heart and pump oxygenated blood out to the rest of the body. This